Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Sept 2026 for Xeris Biopharma Holdings, Inc., €559k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Kevin Mcculloch: trading record in brief
Kevin Mcculloch discloses dealings in Xeris Biopharma Holdings, Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 1 July 2026 and the latest from 28 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 28 September 2026, the filings show a transaction worth €559k in Xeris Biopharma Holdings, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Kevin Mcculloch
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
70,000 shares@ US$9.10CommonSEC144:0001950047-26-009839
120,000 shares@ US$7.920.058% mcap100.0% of flowCommonSEC144:0001950047-26-006705
2 of 2 declarations
